Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

October 25, 2014

Proactive discussion about BPH

BPH can be accurately diagnosed using a set of simple tests that can be easily implemented in the primary care setting, attendees at the EAU Congress heard.

Profal

Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Finasteride 5mg Description: Blue, round, biconvex film-coated tablet marked F5. Presentation: 28, €20.66. Indications: Treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate to cause regression of the enlarged prostate, improve urinary flow and improve the symptoms associated [...]

Carsem XL

Company: Teva Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Doxazosin (as mesilate), 4mg. Description: White, round biconvex film-coated prolonged-release tablets with DL bossing on one side. Presentation: 28, €12.82. Indications: Essential hypertension: Not appropriate for first-line treatment, may be used as a monotherapy in patients who have failed to respond to or [...]

Finasteride Ranbaxy

Company: Ranbaxy UK. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Finasteride 5mg. Description: White, round, biconvex, film-coated tablet, diameter 7 mm, embossed F and 5 on one side. Presentation: 28, €17.88. Indications: Treatment and control of benign prostatic hyperplasia (BPH) to cause regression of the enlarged prostate, improve urinary flow and improve the symptoms [...]

Fintex

Company: Helsinn Birex Therapeutics Ltd. Legal category: Prescription. GMS pending. Sport permitted. Active ingredient: Finasteride 5mg. Description: Blue, 7mm, round biconvex, film-coated tablets marked F5 on one side. Presentation: 28, €17.00. Indications: Treatment and control of benign prostatic hyperplasia (BPH) and prevention of urologic events to reduce the risk of acute urinary retention, reduce the [...]

Finocar

Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Finasteride 5mg. Description: Light blue spherical biconvex film-coated tablet. Presentation: 28, €22.76. Indications: Treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate (prostate volume above 40ml) to cause regression of the enlarged prostate, improve urinary flow and improve the [...]

Tevax

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Alfuzosin hydrochloride10mg. Description: White, round, bevelled-edges, prolonged releasetablet. Presentation: 30, €18.78. Indications: Moderate to severe functional symptoms of benignprostatic hyperplasia (BPH). Pharmacology: Alfuzosin is an orally acting quinazolin derivative,which selectively blocks post-synaptic alpha-1-receptors and thus relaxessmooth muscle and improves urinary flow. Dosage: Adult: [...]